Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of naturally occurring GLP-1, a hormone released by the intestines after eating
We will reply to you as soon as possible after we see the message.
During your consultation, your provider will review your medical history, goals, and current health to determine whether peptide therapy is an appropriate option as part of your personalized wellness plan.
It is worth stating plainly that this lean subgroup is exactly where the read-across from obesity, diabetes, and MASLD data is weakest: those trials enrolled few, if any, participants resembling a normal-weight woman with androgen-driven, intrinsic insulin resistance, so the confidence interval around any predicted effect in her is wide and honestly unknowable from the current evidence
30 DAYS SUPPLY - the bottle includes 30 chewable GlutActive tablets